A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc.
A2 Biotherapeutics Inc.
Takeda
Novartis
7 Hills Pharma, LLC
A2 Biotherapeutics Inc.
Quadriga Biosciences, Inc.
Valerio Therapeutics
Valerio Therapeutics